Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2470 (LINC02470)

Target
LINC02470
Molecular classification
Long non-coding RNA, Competing endogenous RNA (ceRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2470 (LINC02470) is a long non-coding RNA highly upregulated in bladder cancer and associated with poor patient prognosis. At the molecular level, LINC02470 acts as a competing endogenous RNA (ceRNA), sponging microRNA-143-3p and thereby preventing degradation of SMAD3 mRNA. This leads to increased SMAD3 expression and activation of the TGF-β-induced epithelial-to-mesenchymal transition (EMT), promoting cancer cell viability, migration, invasion, and tumorigenicity. LINC02470 is considered a promising biomarker and therapeutic target candidate in bladder cancer, but no drugs currently target it directly, and its safety profile as a therapeutic target is unknown. Alternate transcript ID AC091814.2 is an alias used interchangeably. Given its role in EMT, LINC02470 may be involved in broader cancer biology beyond bladder cancer, but most evidence is currently limited to this malignancy.

Other names
LINC02470AC091814.2
02

Mechanism of action

No direct drugs targeting, but mechanistic role includes sponging miR-143-3p and activating SMAD3/TGF-β signaling.

03

Biological functions

Regulation of epithelial-to-mesenchymal transition (EMT)Cell proliferationCell migrationCell invasionCell cycle progressionRegulation of gene expression via miRNA sponging
04

Disease associations

Cancer (specifically bladder cancer)Other (potentially applicable to additional malignancies, but main evidence in bladder cancer)
05

Biomarkers

LINC02470 expression as a prognostic marker for bladder cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2470 (LINC02470).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2470 (LINC02470).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call